Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19

BACKGROUND: We investigated the feasibility of two biomarkers of endothelial damage (Syndecan-1 and thrombomodulin) in coronavirus disease 2019 (COVID-19), and their association with inflammation, coagulopathy, and mortality. METHODS: The records of 49 COVID-19 patients who were admitted to an inten...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dong, Li, Liubing, Chen, Yu, Ma, Jie, Yang, Yanli, Aodeng, Surita, Cui, Qiuju, Wen, Kedi, Xiao, Meng, Xie, Jing, Xu, Yingchun, Li, Yongzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640509/
https://www.ncbi.nlm.nih.gov/pubmed/34861818
http://dx.doi.org/10.1186/s10020-021-00412-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640509/
https://www.ncbi.nlm.nih.gov/pubmed/34861818
http://dx.doi.org/10.1186/s10020-021-00412-1

Ejemplares similares